Peer review reports
From: Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study
Original Submission | ||
---|---|---|
25 Sep 2022 | Submitted | Original manuscript |
10 Oct 2022 | Reviewed | Reviewer Report - Nóra Garam |
11 Nov 2022 | Reviewed | Reviewer Report |
26 Nov 2022 | Reviewed | Reviewer Report - Teresa Cavero |
8 Dec 2022 | Author responded | Author comments - Thomas Welte |
Resubmission - Version 2 | ||
8 Dec 2022 | Submitted | Manuscript version 2 |
9 Dec 2022 | Author responded | Author comments - Thomas Welte |
Resubmission - Version 3 | ||
9 Dec 2022 | Submitted | Manuscript version 3 |
22 Dec 2022 | Reviewed | Reviewer Report - Teresa Cavero |
27 Dec 2022 | Reviewed | Reviewer Report - Nóra Garam |
28 Dec 2022 | Author responded | Author comments - Thomas Welte |
Resubmission - Version 4 | ||
28 Dec 2022 | Submitted | Manuscript version 4 |
2 Jan 2023 | Reviewed | Reviewer Report - Nóra Garam |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
3 Jan 2023 | Editorially accepted | |
11 Jan 2023 | Article published | 10.1186/s12882-023-03058-9 |